EUCTR2008-002060-34-AT进行中（未招募）不适用
Impact of Inhibition of Thrombocyte Activation on the course of chronic Hepatitis C
Medizinische Universität Wien; Univ.Klin.f.Innere Med. III, Abt.f.Gastroenterologie u. Hepatologie0 个研究点开始时间: 2008年10月21日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- confirmed chronic hepatitis C (IFN-naive or non-responders/relapsers to previous therapy)
- •-ALAT (GPT) > 80 U/l for women, and > 90 U/l for men. These values represent double the upper limit of the normal range of ALAT, which is different for males and females.
- •-Age: 19 years or older
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years)
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Cirrhosis: CHILD-PUGH Stage B and C
- •-Impaired haemostasis (PTZ < 50)
- •-Impaired kidney function (Creatinine > 1.3mg/dl)
- •-Co-infection with HBV or HIV
- •-Platelet count < 50,000/µl
- •- History of variceal bleeding or evidence of GI blood loss
- •- History of thromboembolic or severe cardiovascular disease
- •-Hypertension not responding to anti-hypertensive treatment
- •-History of convulsion
- •-Participation in a clinical trial in the 3 weeks preceding the study
- •-IFN-therapy within 6 months of inclusion into the study.
- •-Use of anti-thrombotic or anticoagualant medication.
- •-Pregnancy
研究者
相似试验
招募中
不适用
Potential influence of coagulation inhibitionon the perception of fear or aggressivenessI48Atrial fibrillation and flutterDRKS00017043niversitätsklinik für Kardiologie und Angiologie25
已完成
不适用
Impact of continued use of antithrombotic drugs on the risk of delayed post-polypectomy bleeding after endoscopic mucosal resection/endoscopic submucosal dissection for gastrointestinal lesions; prospective studyJPRN-UMIN000040449agaoka Red Cross Hospital283
已完成
不适用
Impact of antithrombotic agent on the clinical course after pancreatectomyperioperative complicationJPRN-UMIN000027919ara Medical University1,000
已完成
不适用
Effects of antithrombotic drugs on thrombosis and bleeding risk in patients undergoing thoracic surgerythrombosisbleedingBlood - Other blood disordersBlood - Clotting disordersACTRN12619001417178Ayten Saracoglu100
进行中（未招募）
1 期
The prevention of thrombosis in patients with pancreatic cancer using TinzapariThromboprophylaxis in patients with advanced pancreatic cancerMedDRA version: 20.0Level: PTClassification code 10043607Term: ThrombosisSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 21.1Level: PTClassification code 10068067Term: Tumour thrombosisSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-005530-42-GRInstitute of Molecular Medicine and Biomedical Research (IMBE)450